Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Standard of care
A guideline for the treatment of a condition that can be general or specific. Scientific evidence is gathered to help professionals determine the level of care a patient should expect
See also:
Primary Care Trust (PCT)
Quality of life (QOL)
Related terms
NHS Direct, e-Detailing, Alternative service providers (ASP), Concordance, Cost-minimisation analysis (CMA), Health Maintenance Organisation (HMO), Secondary care, Primary care, Cost-effectiveness threshold (health economics), Utility weighted index, Acute care, e-Prescribing, Foundation Trust (FT), Economic regulation, e-Sampling,
COVID-19 Updates and Daily News
Featured jobs
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
-
Account Manager
-
Competitive salary with bonus and benefits
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- GSK appoint Tony Wood as chief scientific officer
- Almirall and IRB Barcelona announce new research collaboration
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- PM announces plans to lift England’s COVID-19 restrictions
- Expanding Access to High-Quality Healthcare
- FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments
- Janssen’s Tremfya receives positive results for active psoriatic arthritis
- ARISE - a strategic healthcare communication planning process from Bedrock
- Pfizer and BioNTech start clinical trial for Omicron-based COVID-19 vaccine
- FDA restricts use of certain antibody treatments for COVID-19
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Why pharma must get smart in its approach to customer engagement
- WHITE PAPER: Gender inequality—how COVID-19 impacted women
- FDA places partial clinical hold on three Gilead phase 3 trials for MDS and AML treatments
- Janssen’s Tremfya receives positive results for active psoriatic arthritis
- AstraZeneca’s oncology renaissance
